[Eosinophilic fasciitis (Shulman syndrome). Differential diagnosis of chronic eosinophilia-myalgia syndrome after L-tryptophan administration].
Schnabel
A
A
Abteilung Klinische Rheumatologie, Medizinischen Universität Lübeck.
Reusch
M
M
Christophers
E
E
Gross
W L
WL
D000273:Adipose Tissue / Q000473:pathology; D001706:Biopsy; D003238:Connective Tissue / Q000473:pathology; D003937:Diagnosis, Differential; D004802:Eosinophilia / Q000175:diagnosis* / Q000473:pathology; D016603:Eosinophilia-Myalgia Syndrome / Q000175:diagnosis* / Q000473:pathology; D005205:Fascia / Q000473:pathology; D005208:Fasciitis / Q000175:diagnosis* / Q000473:pathology; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D012867:Skin / Q000473:pathology; D014364:Tryptophan / Q000008:administration & dosage / Q000009:adverse effects*
D014364:Tryptophan
Eosinophile Fasziitis (Shulman-Syndrom). DD chronisches Eosinophilie-Myalgie-Syndrom nach L-Tryptophan.